Get the Stockscreener App
46.80
1.21%
0.56
After Hours:
46.80
Qiagen Nv stock is traded at $46.80, with a volume of 1.07M.
It is up +1.21% in the last 24 hours and up +0.21% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
See More
Previous Close:
$46.24
Open:
$46.27
24h Volume:
1.07M
Relative Volume:
0.82
Market Cap:
$10.03B
Revenue:
$1.98B
Net Income/Loss:
$83.59M
P/E Ratio:
125.13
EPS:
0.374
Net Cash Flow:
$502.31M
1W Performance:
+6.61%
1M Performance:
+0.21%
6M Performance:
+15.93%
1Y Performance:
+4.50%
1-Day Range:
$46.23
$46.88
1-Week Range:
$43.74
$46.88
52-Week Range:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
46.80 | 10.03B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
111 Capital Purchases Shares of 47,321 Qiagen N.V. $QGEN - MarketBeat
QIAGEN (NYSE:QGEN) Stock Rating Lowered by Wall Street Zen - MarketBeat
Will Qiagen N.V. stock attract more institutional investorsJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Can Qiagen N.V. (QIA) stock deliver double digit returns2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
How Qiagen N.V. stock reacts to oil pricesPortfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strate... - ADVFN
How geopolitical risks impact Qiagen N.V. Common Shares stockMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Does Qiagen N.V. Common Shares stock trade below intrinsic valueTrade Risk Summary & Detailed Earnings Play Alerts - newser.com
Will Qiagen N.V. price bounce be sustainableWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com
Why Qiagen N.V. (QIA) stock appears on watchlistsWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Can Qiagen N.V. (QIA) stock deliver consistent EPS growthMarket Activity Report & AI Driven Stock Reports - newser.com
What dividend safety score for Qiagen N.V. stock2025 Key Lessons & Daily Technical Forecast Reports - newser.com
Statistical indicators supporting Qiagen N.V.’s strength2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
How cyclical is Qiagen N.V. (QIA) stock compared to rivalsBull Run & Real-Time Volume Spike Alerts - newser.com
Qiagen (QGEN) Analyst Maintains Rating But Lowers Price Target | QGEN Stock News - GuruFocus
Barclays Maintains Qiagen NV(QGEN.US) With Buy Rating, Cuts Target Price to $53 - 富途牛牛
QIAGEN N.V. Pre-announces 2025 Half-Year Financial Report - MSN
Sysmex : Partners with QIAGEN for Exclusive Distribution and Supply of Clinical Diagnostic Products in Infectious Diseases and Oncology in Japan - MarketScreener
Qiagen N : Halfjaarlijkse financiële verslaggeving - MarketScreener
What drives Qiagen NV QIA stock priceMarket Entry Points & Low Risk Trading Portfolio - earlytimes.in
What analysts say about Qiagen NV stockInsider Trading Activity & Affordable Investment Portfolio - earlytimes.in
Is Qiagen NV a good long term investmentMomentum Trading Signals & Budget Friendly Trading Ideas - earlytimes.in
What drives Qiagen NV stock priceInsider Selling Patterns & Low Risk Investment Growth - Early Times
Baird Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $43 - 富途牛牛
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.01%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):